Vivitra 440mg Dry Vial Of 1 Powder For Injection
By ZYDUS LIFESCIENCES LIMITED
Refrigerated
1 Powder For Injection(s) in Dry Vial
MRP ₹35920.00
₹31609.6012% OFF
Inclusive of all taxes
Out of Stock
15 days return policyRead More
All the Products are packed and stored Safely
Vivitra 440 MG Description
Vivitra powder for injection is an anti-cancer medication used by cancer specialists to treat specific types of breast cancer. It targets a protein called HER2, which is overexpressed in certain breast cancers. By binding to HER2, Vivitra powder for injection inhibits the growth of these cancer cells. Vivitra powder for injection is used in various treatment settings, including early-stage breast cancer with high HER2 levels and metastatic breast cancer. It may be administered alone or in combination with other cancer treatments like chemotherapy or hormone therapy, depending on the specific type and stage of the cancer.
Product Summary
Offer Price | ₹31609.60 |
You Save | ₹4310.40 (12% on MRP) |
Contains | Trastuzumab(440.0 Mg) |
Uses | Breast cancers |
Side effects | Chills, fever, flu-like symptoms, nausea, vomiting, increased muscle tension |
Therapy | ANTI-NEOPLASTIC |
Check more medicines with composition as Trastuzumab(440.0 Mg)
Uses of Vivitra 440 MG
Vivitra powder for injection is used by cancer specialists in the treatment of breast cancers.
Contraindications of Vivitra 440 MG
- If you are allergic to trastuzumab or any of the other ingredients of Vivitra powder for injection.
- If you have severe breathing problems at rest due to your cancer or if you need oxygen treatment.
Side effects of Vivitra 440 MG
- Chills
- Fever
- Flu-like symptoms
- Nausea
- Vomiting
- Increased muscle tension
- Shaking
- Headache
- Dizziness
- Breathing difficulties
- High or low blood pressure
- Heart rhythm disturbances (palpitations, heart fluttering, irregular heartbeat)
- Swelling of the face and lips
- Rash
- Fatigue (feeling tired)
Precautions and Warnings of Vivitra 440 MG
Pregnancy
Q:
Can I take Vivitra powder for injection during pregnancy?
A:
Vivitra powder for injection should be avoided in pregnancy and during treatment with this injection and after 7 months after treatment has ended, it is advised to use an effective method of contraception.
Breast Feeding
Q:
Can I take Vivitra powder for injection while breastfeeding?
A:
Vivitra powder for injection can pass into breast milk, which could potentially harm a breastfeeding baby. Therefore, it's strongly recommended to avoid breastfeeding during Vivitra powder for injection treatment and for 7 months after the last dose of the medication.
Driving
Q:
Can I drive if I have taken Vivitra powder for injection?
A:
Vivitra powder for injection treatment may affect your ability to drive or operate machinery. If you experience side effects like dizziness, sleepiness, chills, or fever during treatment, avoiding driving or operating machinery is crucial until these symptoms subside.
Alcohol
Q:
Can I consume alcohol with Vivitra powder for injection?
A:
No known interactions with alcohol.
Other General Warnings
Talk to your doctor if
- You have ever had or might now have a hepatitis infection.
- You have a history of cardiac conditions, such as heart failure, coronary artery disease, or arrhythmias.
- You have previously received anthracycline-based chemotherapy.
- You experience symptoms of cardiac dysfunction, including shortness of breath, fatigue, or swelling.
- You have poorly controlled hypertension or other cardiovascular risk factors.
- You have a history of myocardial infarction, angina requiring treatment, or clinically significant valvular disease.
- You suffer from asthma or other respiratory conditions.
- You develop symptoms during or after infusion, such as shortness of breath, wheezing, hypotension, hypertension, urticaria, or chest pain.
- You experience delayed infusion-related symptoms hours or days after treatment.
- You have dyspnea (difficulty breathing) at rest due to advanced malignancy or other comorbidities.
- You experience any new or worsening respiratory symptoms, such as cough, chest tightness, or difficulty breathing.
- You have been treated with Vivitra powder for injection before and are considering re-treatment.
- You are pregnant, planning a pregnancy, or breastfeeding.
- You experience severe side effects, including persistent nausea, fatigue, or signs of infection.
- You notice worsening symptoms or develop new symptoms during treatment.
- You are taking other medications, especially those known to affect the heart or lungs, such as taxanes, gemcitabine, or radiation therapy.
Directions for Use of Vivitra 440 MG
Vivitra powder for injection will be given to you in the hospital by your doctor or nurse. Follow any instructions suggested by the doctor or nurse during the procedure or for aftercare.
Storage and disposal of Vivitra 440 MG
- Store in a refrigerator (2 °C – 8 °C). Keep the container in the outer carton to protect it from light.
- Keep it out of the reach of children
Dosage of Vivitra 440 MG
Overdose
Your doctor or nurse will give Vivitra powder for injection. Therefore, the chances of overdose are very rare. If you experience the symptoms right after taking the injection, seek medical help.
Missed a Dose
Your doctor or nurse will carefully monitor and schedule your injections, making it unlikely for a dose to be missed. However, if you suspect a dose might have been overlooked, let them know immediately....
Mode of Action of Vivitra 440 MG
How Does It Work?
Trastuzumab is a targeted cancer therapy that specifically targets cancer cells overproducing the HER2 protein. By attaching to HER2, it inhibits cell growth and division. It enhances the immune system's ability to recognize and eliminate these cancer cells. Trastuzumab primarily affects HER2-positive cancer cells, minimizing its impact on healthy cells, and making it a valuable treatment option for these cancers....
Interactions of Vivitra 440 MG
Interactions with other medicines
Tell your doctor about all the medicines, supplements or herbals you are currently taking or might take to avoid any possible interaction.
Content Details
WRITTEN BY
Ravindra Ghongade
B. Pharm
REVIEWED BY
Dr. Nikita Toshi
BDS (Bachelor of Dental Surgery)
References
- Herceptin 150mg Powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 6 January 2025]
- Herceptin 150mg Powder for concentrate for solution for infusion - Patient Information Leaflet (PIL) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 6 January 2025]
Product Details
Brand
VIVITRA
Expires on or After
06/05/2025
Manufacturer Details
Other Products from this Brand
Health Articles
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
Please add item(s) to proceed